Different T cell related immunological profiles in COVID-19 patients compared to healthy controls.
Adult
Aged
COVID-19
/ blood
Cytokines
/ immunology
Female
Healthy Volunteers
Humans
Immunity, Cellular
Inflammation
/ metabolism
Interferon-gamma
/ metabolism
Interleukin-10
/ metabolism
Interleukin-17
/ metabolism
Interleukin-4
/ metabolism
Leukocytes
/ immunology
Male
Middle Aged
Severity of Illness Index
T-Lymphocyte Subsets
/ immunology
T-Lymphocytes, Regulatory
/ immunology
Th1 Cells
/ immunology
Th17 Cells
/ immunology
Th2 Cells
/ immunology
Young Adult
COVID-19
Cell mediated immunity
Inflammation
T cells
Journal
International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
23
03
2021
revised:
25
05
2021
accepted:
25
05
2021
pubmed:
7
6
2021
medline:
24
8
2021
entrez:
6
6
2021
Statut:
ppublish
Résumé
In various pathological conditions, cellular immunity plays an important role in immune responses. Amongimmunecells, T lymphocytes pdomotecellular and humoralresponses as well as innate immunity. Therefore, careful investigation of these cells has a significant impact on accurate knowledge in COVID-19diseasepathogenesis. In current research, the frequency and function of various T lymphocytes involved in immune responses examined in SARS-CoV-2 patients with various disease severity compared to normal subjects. In order to make an accurate comparison among patients with various disease severity, this study was performed on asymptomatic recovered cases (n = 20), ICU hospitalized patients (n = 30), non-ICU hospitalized patients (n = 30), and normal subjects (n = 20). To precisely evaluate T cells activity following purification, their cytokine secretion activity was examined. Similarly, immediately after purification of Treg cells, their inhibitory activity on T cells was investigated. The results showed that COVID-19 patients with severe disease (ICU hospitalized patients) not only had a remarkable increase in Th1 and Th17 but also a considerable decrease in Th2 and Treg cells. More importantly, as the IL-17 and IFN-γ secretion was sharply increased in severe disease, the secretion of IL-10 and IL-4 was decreased. Furthermore, the inhibitory activity of Treg cells was reduced in severe disease patients in comparison to other groups. In severe COVID-19 disease, current findings indicate when the inflammatory arm of cellular immunity is significantly increased, a considerable reduction in anti-inflammatory and regulatory arm occurred.
Identifiants
pubmed: 34091116
pii: S1567-5769(21)00464-1
doi: 10.1016/j.intimp.2021.107828
pmc: PMC8162824
pii:
doi:
Substances chimiques
Cytokines
0
IFNG protein, human
0
IL10 protein, human
0
IL4 protein, human
0
Interleukin-17
0
Interleukin-10
130068-27-8
Interleukin-4
207137-56-2
Interferon-gamma
82115-62-6
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
107828Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.
Références
Immunopharmacol Immunotoxicol. 2012 Oct;34(5):727-39
pubmed: 22316060
Front Med (Lausanne). 2020 Jun 09;7:301
pubmed: 32582743
Cell. 2020 Nov 25;183(5):1340-1353.e16
pubmed: 33096020
Int J Biol Macromol. 2019 Jul 15;133:436-445
pubmed: 30936011
Ann Allergy Asthma Immunol. 2000 Jul;85(1):9-18; quiz 18, 21
pubmed: 10923599
Lancet Respir Med. 2020 Jun;8(6):e46-e47
pubmed: 32353251
Life Sci. 2021 Nov 1;284:119132
pubmed: 33513396
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
J Exp Med. 2020 Jun 1;217(6):
pubmed: 32302401
Emerg Infect Dis. 2010 Jan;16(1):41-7
pubmed: 20031041
Cancer Invest. 2013 Feb;31(2):121-31
pubmed: 23286587
Allergy. 2021 Mar;76(3):866-868
pubmed: 32479648
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
J Cell Physiol. 2020 Dec;235(12):9211-9229
pubmed: 32452050
Int J Biol Macromol. 2020 Apr 15;149:487-500
pubmed: 32004600
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Cell. 2020 Jun 11;181(6):1194-1199
pubmed: 32405102
Immunol Res. 2001;24(1):53-67
pubmed: 11485209
Vascul Pharmacol. 2002 Nov;39(4-5):247-56
pubmed: 12747964
Biostat Bioinforma Biomath. 2013 Aug;3(3):71-85
pubmed: 25558171
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213
pubmed: 32215952
Pathol Res Pract. 2020 Dec;216(12):153247
pubmed: 33190014
J Leukoc Biol. 2021 Jan;109(1):13-22
pubmed: 33040384
Nat Commun. 2020 Jul 6;11(1):3434
pubmed: 32632085
Immunology. 2020 Jan;159(1):75-87
pubmed: 31587253
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
J Pharm Anal. 2020 Apr;10(2):102-108
pubmed: 32282863
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Front Mol Biosci. 2020 Jul 03;7:157
pubmed: 32719810
Neurology. 1990 Nov;40(11):1770-6
pubmed: 1700336
Crit Care. 2009;13(6):R201
pubmed: 20003352
Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):E3246-54
pubmed: 26060310
Arch Med Res. 2020 Oct;51(7):721-722
pubmed: 32471704
Front Cell Infect Microbiol. 2021 Feb 26;11:624483
pubmed: 33718270
J Chin Med Assoc. 2020 Mar;83(3):217-220
pubmed: 32134861
Syst Biol Reprod Med. 2017 Dec;63(6):350-359
pubmed: 29099629
Int J Surg. 2020 Apr;76:71-76
pubmed: 32112977
J Exp Med. 2007 Aug 6;204(8):1849-61
pubmed: 17635957
Eur J Immunol. 2020 Dec;50(12):2013-2024
pubmed: 33080068
Natl Sci Rev. 2020 Jun;7(6):1003-1011
pubmed: 34676126
Lancet Infect Dis. 2020 Apr;20(4):400-402
pubmed: 32113509
Respir Med Case Rep. 2020 May 13;30:101090
pubmed: 32405454
Vaccines (Basel). 2020 Nov 12;8(4):
pubmed: 33198287
J Microbiol Immunol Infect. 2020 Jun;53(3):368-370
pubmed: 32205092
Cell Mol Immunol. 2020 May;17(5):533-535
pubmed: 32203188
J Cell Physiol. 2021 Apr;236(4):2829-2839
pubmed: 32926425
Microbiol Immunol. 2017 Feb;61(2):49-56
pubmed: 28225165
Front Immunol. 2020 Nov 26;11:596553
pubmed: 33324414
Immunology. 2020 Jul;160(3):261-268
pubmed: 32460357
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Clin Invest. 2020 Sep 1;130(9):4694-4703
pubmed: 32463803
J Immunol. 2020 Aug 15;205(4):892-898
pubmed: 32651218
Int J Biol Macromol. 2021 Jan 15;167:1006-1019
pubmed: 33227333
JAMA. 2020 Mar 24;323(12):1122
pubmed: 32207769
Cell Mol Immunol. 2020 May;17(5):541-543
pubmed: 32203186
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Nat Med. 2013 Mar;19(3):322-8
pubmed: 23396208
Int J Oral Sci. 2020 Feb 24;12(1):8
pubmed: 32094336
Int J Infect Dis. 2020 Jun;95:332-339
pubmed: 32334118
Rev Med Virol. 2020 May;30(3):e2107
pubmed: 32267987
Eur J Immunol. 2020 Dec;50(12):1998-2012
pubmed: 33073359
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Nat Immunol. 2005 Nov;6(11):1123-32
pubmed: 16200070